These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38923845)
1. Psychotomimetic compensation versus sensitization. Brouwer A; Carhart-Harris RL; Raison CL Pharmacol Res Perspect; 2024 Aug; 12(4):e1217. PubMed ID: 38923845 [TBL] [Abstract][Full Text] [Related]
2. Psychedelic drugs, stress, and the ego. The differential diagnosis of psychosis associated with psychotomimetic drug use. Glass GS J Nerv Ment Dis; 1973 Apr; 156(4):232-41. PubMed ID: 4708883 [No Abstract] [Full Text] [Related]
3. The abuse of psychotomimetic drugs. Frosch WA Int J Addict; 1971 Jun; 6(2):299-308. PubMed ID: 5163943 [No Abstract] [Full Text] [Related]
4. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. Potvin S; Stip E; Roy JY Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543 [TBL] [Abstract][Full Text] [Related]
5. Psychotomimetic effects of anorectic drugs. Khan SA; Spiegel DA; Jobe PC Am Fam Physician; 1987 Aug; 36(2):107-12. PubMed ID: 3618447 [TBL] [Abstract][Full Text] [Related]
6. Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC. Bhattacharyya S; Sainsbury T; Allen P; Nosarti C; Atakan Z; Giampietro V; Brammer M; McGuire PK Psychol Med; 2018 Dec; 48(16):2748-2756. PubMed ID: 29502548 [TBL] [Abstract][Full Text] [Related]
7. Substance-induced psychoses: a critical review of the literature. Fiorentini A; Volonteri LS; Dragogna F; Rovera C; Maffini M; Mauri MC; Altamura CA Curr Drug Abuse Rev; 2011 Dec; 4(4):228-40. PubMed ID: 21999698 [TBL] [Abstract][Full Text] [Related]
8. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Dourron HM; Strauss C; Hendricks PS Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878 [TBL] [Abstract][Full Text] [Related]
9. Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings. Bowers MB Arch Gen Psychiatry; 1972 Oct; 27(4):437-40. PubMed ID: 5072710 [No Abstract] [Full Text] [Related]
16. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study. Rosse RB; Collins JP; Fay-McCarthy M; Alim TN; Wyatt RJ; Deutsch SI Clin Neuropharmacol; 1994 Aug; 17(4):359-69. PubMed ID: 9316684 [TBL] [Abstract][Full Text] [Related]
17. Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis. Murrie B; Lappin J; Large M; Sara G Schizophr Bull; 2020 Apr; 46(3):505-516. PubMed ID: 31618428 [TBL] [Abstract][Full Text] [Related]
18. Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies. Ganesh S; Cortes-Briones J; Ranganathan M; Radhakrishnan R; Skosnik PD; D'Souza DC Int J Neuropsychopharmacol; 2020 Dec; 23(9):559-570. PubMed ID: 32385508 [TBL] [Abstract][Full Text] [Related]
19. PCP (phencyclidine): an update. Garey RE J Psychedelic Drugs; 1979; 11(4):265-75. PubMed ID: 42808 [TBL] [Abstract][Full Text] [Related]
20. [Phencyclidine (PCP): a psychotomimetic drug. Case report and review of literature]. Stodieck SR Schweiz Med Wochenschr; 1983 Oct; 113(39):1396-402. PubMed ID: 6635638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]